vs
Side-by-side financial comparison of SIFCO INDUSTRIES INC (SIF) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
ARS Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($28.1M vs $24.0M, roughly 1.2× SIFCO INDUSTRIES INC). SIFCO INDUSTRIES INC runs the higher net margin — 7.5% vs -147.1%, a 154.6% gap on every dollar of revenue. On growth, SIFCO INDUSTRIES INC posted the faster year-over-year revenue change (14.8% vs -67.6%).
SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
SIF vs SPRY — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.0M | $28.1M |
| Net Profit | $1.8M | $-41.3M |
| Gross Margin | 21.6% | — |
| Operating Margin | 10.7% | -147.6% |
| Net Margin | 7.5% | -147.1% |
| Revenue YoY | 14.8% | -67.6% |
| Net Profit YoY | 177.3% | -182.8% |
| EPS (diluted) | $0.29 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.0M | $28.1M | ||
| Q3 25 | $22.8M | $32.5M | ||
| Q2 25 | $22.1M | $15.7M | ||
| Q1 25 | $19.0M | $8.0M | ||
| Q4 24 | $20.9M | $86.6M | ||
| Q3 24 | $21.7M | $2.1M | ||
| Q2 24 | $22.0M | $500.0K | ||
| Q1 24 | $20.5M | $0 |
| Q4 25 | $1.8M | $-41.3M | ||
| Q3 25 | $-429.0K | $-51.2M | ||
| Q2 25 | $3.4M | $-44.9M | ||
| Q1 25 | $-1.4M | $-33.9M | ||
| Q4 24 | $-2.3M | $49.9M | ||
| Q3 24 | $-443.0K | $-19.1M | ||
| Q2 24 | $72.0K | $-12.5M | ||
| Q1 24 | $-1.6M | $-10.3M |
| Q4 25 | 21.6% | — | ||
| Q3 25 | 9.6% | — | ||
| Q2 25 | 26.7% | — | ||
| Q1 25 | 8.3% | — | ||
| Q4 24 | 4.4% | — | ||
| Q3 24 | 10.7% | — | ||
| Q2 24 | 12.3% | — | ||
| Q1 24 | 7.3% | — |
| Q4 25 | 10.7% | -147.6% | ||
| Q3 25 | -1.7% | -163.7% | ||
| Q2 25 | 14.8% | -302.9% | ||
| Q1 25 | -4.1% | -466.3% | ||
| Q4 24 | -9.2% | 54.5% | ||
| Q3 24 | -1.5% | -1051.6% | ||
| Q2 24 | 0.7% | -3068.0% | ||
| Q1 24 | -6.5% | — |
| Q4 25 | 7.5% | -147.1% | ||
| Q3 25 | -1.9% | -157.4% | ||
| Q2 25 | 15.4% | -285.6% | ||
| Q1 25 | -7.3% | -425.7% | ||
| Q4 24 | -11.1% | 57.7% | ||
| Q3 24 | -2.0% | -925.0% | ||
| Q2 24 | 0.3% | -2503.2% | ||
| Q1 24 | -7.8% | — |
| Q4 25 | $0.29 | $-0.41 | ||
| Q3 25 | $-0.07 | $-0.52 | ||
| Q2 25 | $0.56 | $-0.46 | ||
| Q1 25 | $-0.23 | $-0.35 | ||
| Q4 24 | $-0.38 | $0.52 | ||
| Q3 24 | $-0.07 | $-0.20 | ||
| Q2 24 | $0.01 | $-0.13 | ||
| Q1 24 | $-0.27 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.1M | $245.0M |
| Total DebtLower is stronger | $39.0K | $96.4M |
| Stockholders' EquityBook value | $38.7M | $114.3M |
| Total Assets | $74.9M | $327.7M |
| Debt / EquityLower = less leverage | 0.00× | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.1M | $245.0M | ||
| Q3 25 | $491.0K | $288.2M | ||
| Q2 25 | $2.0M | $240.1M | ||
| Q1 25 | $1.9M | $275.7M | ||
| Q4 24 | $3.1M | $314.0M | ||
| Q3 24 | $1.7M | $204.6M | ||
| Q2 24 | $3.4M | $218.7M | ||
| Q1 24 | $2.5M | $223.6M |
| Q4 25 | $39.0K | $96.4M | ||
| Q3 25 | $51.0K | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $3.6M | — | ||
| Q1 24 | $4.1M | — |
| Q4 25 | $38.7M | $114.3M | ||
| Q3 25 | $36.9M | $147.7M | ||
| Q2 25 | $35.8M | $192.3M | ||
| Q1 25 | $32.4M | $229.0M | ||
| Q4 24 | $33.7M | $256.8M | ||
| Q3 24 | $30.4M | $201.0M | ||
| Q2 24 | $29.8M | $215.2M | ||
| Q1 24 | $29.7M | $223.9M |
| Q4 25 | $74.9M | $327.7M | ||
| Q3 25 | $73.4M | $372.8M | ||
| Q2 25 | $77.3M | $313.5M | ||
| Q1 25 | $78.8M | $327.3M | ||
| Q4 24 | $81.0M | $351.2M | ||
| Q3 24 | $104.6M | $217.6M | ||
| Q2 24 | $106.3M | $222.0M | ||
| Q1 24 | $104.2M | $227.6M |
| Q4 25 | 0.00× | 0.84× | ||
| Q3 25 | 0.00× | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.1M | $-43.5M |
| Free Cash FlowOCF − Capex | $8.0M | — |
| FCF MarginFCF / Revenue | 33.3% | — |
| Capex IntensityCapex / Revenue | 0.4% | 0.0% |
| Cash ConversionOCF / Net Profit | 4.51× | — |
| TTM Free Cash FlowTrailing 4 quarters | $11.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.1M | $-43.5M | ||
| Q3 25 | $726.0K | $-47.0M | ||
| Q2 25 | $371.0K | $-39.6M | ||
| Q1 25 | $2.8M | $-40.7M | ||
| Q4 24 | $-3.8M | $42.0M | ||
| Q3 24 | $857.0K | $-14.5M | ||
| Q2 24 | $382.0K | $-7.3M | ||
| Q1 24 | $-3.2M | $-6.7M |
| Q4 25 | $8.0M | — | ||
| Q3 25 | $566.0K | $-47.2M | ||
| Q2 25 | $310.0K | $-39.6M | ||
| Q1 25 | $2.7M | $-40.8M | ||
| Q4 24 | $-3.9M | $41.7M | ||
| Q3 24 | $580.0K | $-14.6M | ||
| Q2 24 | $-175.0K | $-7.3M | ||
| Q1 24 | $-3.9M | $-6.8M |
| Q4 25 | 33.3% | — | ||
| Q3 25 | 2.5% | -145.4% | ||
| Q2 25 | 1.4% | -252.2% | ||
| Q1 25 | 14.1% | -512.1% | ||
| Q4 24 | -18.8% | 48.2% | ||
| Q3 24 | 2.7% | -706.3% | ||
| Q2 24 | -0.8% | -1463.4% | ||
| Q1 24 | -18.9% | — |
| Q4 25 | 0.4% | 0.0% | ||
| Q3 25 | 0.7% | 0.6% | ||
| Q2 25 | 0.3% | 0.3% | ||
| Q1 25 | 0.8% | 1.1% | ||
| Q4 24 | 0.5% | 0.3% | ||
| Q3 24 | 1.3% | 6.8% | ||
| Q2 24 | 2.5% | 7.6% | ||
| Q1 24 | 3.3% | — |
| Q4 25 | 4.51× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.31× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SIF
| Fixed Wing Aircraft Revenue | $10.5M | 44% |
| Commercial Revenue | $8.7M | 36% |
| Commercial Product And Other Revenue | $2.8M | 12% |
| Commercial Space | $1.1M | 5% |
| Other | $840.0K | 4% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
